These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32292293)

  • 1. Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats.
    Chogtu B; Ommurugan B; Thomson SR; Kalthur SG
    ScientificWorldJournal; 2020; 2020():4704825. PubMed ID: 32292293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin safety: An experimental study of myotoxic effects and mitochondrial alterations in rats.
    El-Ganainy SO; El-Mallah A; Abdallah D; Khattab MM; Mohy El-Din MM; El-Khatib AS
    Toxicol Lett; 2017 Jan; 265():23-29. PubMed ID: 27815113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D.
    Riphagen IJ; van der Veer E; Muskiet FA; DeJongste MJ
    Curr Med Res Opin; 2012 Jul; 28(7):1247-52. PubMed ID: 22686958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of vitamin D deficiency to statin myopathy.
    Gupta A; Thompson PD
    Atherosclerosis; 2011 Mar; 215(1):23-9. PubMed ID: 21185021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins.
    Kurnik D; Hochman I; Vesterman-Landes J; Kenig T; Katzir I; Lomnicky Y; Halkin H; Loebstein R
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):36-41. PubMed ID: 22211469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment.
    Kang JH; Nguyen QN; Mutka J; Le QA
    J Pharm Pract; 2017 Oct; 30(5):521-527. PubMed ID: 27798247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Vitamin D Levels and Genetic Polymorphism in the Vitamin D Receptor are Associated with Increased Risk of Statin-Induced Myopathy.
    Ovesjö ML; Skilving I; Bergman P; Rane A; Ekström L; Björkhem-Bergman L
    Basic Clin Pharmacol Toxicol; 2016 Mar; 118(3):214-8. PubMed ID: 26423691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SLCO1B1 gene polymorphisms and vitamin D on statin-induced myopathy.
    Alghalyini B; El Shamieh S; Salami A; Visvikis Siest S; Fakhoury HM; Fakhoury R
    Drug Metab Pers Ther; 2018 Mar; 33(1):41-47. PubMed ID: 29420305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low plasma vitamin D levels and muscle-related adverse effects in statin users.
    Eisen A; Lev E; Iakobishvilli Z; Porter A; Brosh D; Hasdai D; Mager A
    Isr Med Assoc J; 2014 Jan; 16(1):42-5. PubMed ID: 24575504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients.
    Calza L; Magistrelli E; Colangeli V; Borderi M; Contadini I; Bon I; Re MC; Viale P
    AIDS; 2017 Mar; 31(5):681-688. PubMed ID: 28060020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge.
    Fung EC; Crook MA
    Cardiovasc Ther; 2012 Oct; 30(5):e212-8. PubMed ID: 21884002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy.
    Dorajoo Rs; Pereira BP; Yu Z; Gopalakrishnakone P; Leong CC; Wee A; Lee E
    Life Sci; 2008 Apr; 82(15-16):823-30. PubMed ID: 18509883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbic acid co-administered with rosuvastatin reduces reproductive impairment in the male offspring from male rats exposed to the statin at pre-puberty.
    Leite GAA; Figueiredo TM; Guerra MT; Borges CDS; Fernandes FH; Anselmo-Franci JA; Kempinas WG
    Food Chem Toxicol; 2018 Aug; 118():416-429. PubMed ID: 29778496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy.
    Sidaway J; Wang Y; Marsden AM; Orton TC; Westwood FR; Azuma CT; Scott RC
    Xenobiotica; 2009 Jan; 39(1):90-8. PubMed ID: 19219751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin: characterization of induced myopathy in the rat.
    Westwood FR; Scott RC; Marsden AM; Bigley A; Randall K
    Toxicol Pathol; 2008 Feb; 36(2):345-52. PubMed ID: 18362199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocalcemic induced increase in creatine kinase in rats.
    Ishikawa T; Kanayama M; Oba T; Horie T
    Pediatr Neurol; 1998 Apr; 18(4):326-30. PubMed ID: 9588528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of muscle damage and high serum concentration of creatine kinase in patients on statin therapy.
    Nogueira AA; Strunz CM; Takada JY; Mansur AP
    Biomark Med; 2019 Jun; 13(8):619-626. PubMed ID: 31157560
    [No Abstract]   [Full Text] [Related]  

  • 19. Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model.
    El-Ganainy SO; El-Mallah A; Abdallah D; Khattab MM; Mohy El-Din MM; El-Khatib AS
    Toxicology; 2016 Jun; 359-360():29-38. PubMed ID: 27345130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects.
    Ramakumari N; Indumathi B; Katkam SK; Kutala VK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S120-S125. PubMed ID: 30595243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.